[Story ID: 3261] HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, announced today results for the second quarter ended June 30, 2010.
[Story ID: 3012] At the 18th AIDS conference 2010 in Vienna, Julio Montaner ‘
[Story ID: 2892] Early detection, diagnosis and care management for people newly diagnosed with cognitive impairment and dementia reduces outpatient costs by almost 30 percent, according to new research reported today at the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 in Honolulu.
[Story ID: 2806] Virtual Radiologic Corporation (“vRad”), a national radiology practice and a leader in the development of radiologist workflow technology, and Providence Equity Partners, a leading global private equity firm that manages over $22 billion in equity capital, announced that earlier today vRad’s stockholders approved and adopted the merger agreement providing for the acquisition [...]
[Story ID: 2760] Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of a research collaboration with Novartis (Basel, Switzerland). This agreement represents the fifth major partnership Adimab has announced since launching its platform at BIO 2009 in Atlanta, just one year ago. In addition, Adimab today announced the [...]
[Story ID: 2646] WEST PALM BEACH, Fla.–Auto theft is one of the biggest problems in the US today.
[Story ID: 2581] American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the 510(k) clearance of its revolutionary MoXy’
[Story ID: 2110] Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company’s wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2009.
[Story ID: 2111] SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the second quarter ended March 31, 2010.
[Story ID: 1872] 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2010.